Chemotherapy and Lapatinib or Trastuzumab in Treating Women With HER2/Neu-Positive Metastatic Breast Cancer
Clinical trial NCT00667251 · COMPLETED
Trial details
- NCT number
- NCT00667251
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-07
- Primary completion
- 2012-08-01
- Enrollment
- 652
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.